These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21935752)

  • 21. Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial.
    Tashkin DP; Rennard SI; Martin P; Ramachandran S; Martin UJ; Silkoff PE; Goldman M
    Drugs; 2008; 68(14):1975-2000. PubMed ID: 18778120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhaler usability of a pressurized metered dose inhaler and a soft mist inhaler in patients with COPD: A simulated-use study.
    Ding B; Siddiqui S; DePietro M; Petersson G; Martin UJ
    Chron Respir Dis; 2019; 16():1479972318787914. PubMed ID: 30016880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating the Effectiveness of Written Dry Powder Inhaler Instructions and Health Literacy in Subjects Diagnosed With COPD.
    Alsomali HJ; Vines DL; Stein BD; Becker EA
    Respir Care; 2017 Feb; 62(2):172-178. PubMed ID: 28028187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of one-on-one coaching in improving pressurized metered dose inhaler (pMDI) technique among COPD patients: a prospective clinical study.
    Kim JS; Hashweh N; Li H; Choudhary S; Santosh S; Charbek E
    BMC Pulm Med; 2021 Aug; 21(1):266. PubMed ID: 34399721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical effectiveness of the Respimat inhaler device in managing chronic obstructive pulmonary disease: evidence when compared with other handheld inhaler devices.
    Ram FS; Carvallho CR; White J
    Int J Chron Obstruct Pulmon Dis; 2011; 6():129-39. PubMed ID: 21468167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating inhaler use technique in COPD patients.
    Pothirat C; Chaiwong W; Phetsuk N; Pisalthanapuna S; Chetsadaphan N; Choomuang W
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1291-8. PubMed ID: 26185435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol.
    Lenferink A; Frith P; van der Valk P; Buckman J; Sladek R; Cafarella P; van der Palen J; Effing T
    Contemp Clin Trials; 2013 Sep; 36(1):81-9. PubMed ID: 23770110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baseline Symptom Score Impact on Benefits of Glycopyrrolate/Formoterol Metered Dose Inhaler in COPD.
    Martinez FJ; Fabbri LM; Ferguson GT; Orevillo C; Darken P; Martin UJ; Reisner C
    Chest; 2017 Dec; 152(6):1169-1178. PubMed ID: 28720336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of budesonide/formoterol pressurized metered-dose inhaler on exacerbations versus formoterol in chronic obstructive pulmonary disease: The 6-month, randomized RISE (Revealing the Impact of Symbicort in reducing Exacerbations in COPD) study.
    Ferguson GT; Tashkin DP; Skärby T; Jorup C; Sandin K; Greenwood M; Pemberton K; Trudo F
    Respir Med; 2017 Nov; 132():31-41. PubMed ID: 29229103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Administration Technique and Acceptance of Inhaler Devices in Patients With Asthma or COPD.
    Sadowski CA; Cor K; Cave A; Banh HL
    Ann Pharmacother; 2015 Jun; 49(6):639-48. PubMed ID: 25814632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is Inhaler Technique Associated with Quality of Life in Patients with Chronic Obstructive Pulmonary Disease?
    Amini S; Ghasemi A; Solduzian M; Rahimi B; Heidari K; Hadjibabaie M; Kargar M
    Curr Ther Res Clin Exp; 2020; 93():100608. PubMed ID: 33296446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial.
    Singh D; Papi A; Corradi M; Pavlišová I; Montagna I; Francisco C; Cohuet G; Vezzoli S; Scuri M; Vestbo J
    Lancet; 2016 Sep; 388(10048):963-73. PubMed ID: 27598678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial.
    Rennard SI; Tashkin DP; McElhattan J; Goldman M; Ramachandran S; Martin UJ; Silkoff PE
    Drugs; 2009; 69(5):549-65. PubMed ID: 19368417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lay Health Coaching to Increase Appropriate Inhaler Use in COPD: A Randomized Controlled Trial.
    Willard-Grace R; Chirinos C; Wolf J; DeVore D; Huang B; Hessler D; Tsao S; Su G; Thom DH
    Ann Fam Med; 2020 Jan; 18(1):5-14. PubMed ID: 31937527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of a Single Session of Inhalation Technique Training on Inhalation Skills and the Course of Asthma and COPD.
    Dabrowska M; Luczak-Wozniak K; Miszczuk M; Domagala I; Lubanski W; Leszczynski A; Maskey-Warzechowska M; Rubinsztajn R; Hermanowicz-Salamon J; Krenke R
    Respir Care; 2019 Oct; 64(10):1250-1260. PubMed ID: 31213572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impacts of a health literacy-informed intervention in people with chronic obstructive pulmonary disease (COPD) on hospitalization, health literacy, self-management, quality of life, and health costs - A randomized controlled trial.
    Borge CR; Larsen MH; Osborne RH; Aas E; Kolle IT; Reinertsen R; Lein MP; Thörn M; Lind RM; Groth M; Strand O; Andersen MH; Moum T; Engebretsen E; Wahl AK
    Patient Educ Couns; 2024 Jun; 123():108220. PubMed ID: 38458089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhaler Technique and Adherence to Inhaled Medications among Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Vietnam.
    Ngo CQ; Phan DM; Vu GV; Dao PN; Phan PT; Chu HT; Nguyen LH; Vu GT; Ha GH; Tran TH; Tran BX; Latkin CA; Ho CSH; Ho RCM
    Int J Environ Res Public Health; 2019 Jan; 16(2):. PubMed ID: 30634631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of Virtual vs In-Person Inhaler Education for Hospitalized Patients With Obstructive Lung Disease: A Randomized Clinical Trial.
    Press VG; Arora VM; Kelly CA; Carey KA; White SR; Wan W
    JAMA Netw Open; 2020 Jan; 3(1):e1918205. PubMed ID: 31899529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Relationship Between Clinical Trial Participation and Inhaler Technique Errors in Asthma and COPD Patients.
    Perumal R; Leite M; van Zyl-Smit RN
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1217-1224. PubMed ID: 32581528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol.
    Rabe KF; Martinez FJ; Ferguson GT; Wang C; Singh D; Wedzicha JA; Trivedi R; St Rose E; Ballal S; McLaren J; Darken P; Reisner C; Dorinsky P
    Respir Med; 2019; 158():59-66. PubMed ID: 31605923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.